Purchase Order 75N98026P01096

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $11,109 firm fixed price BPA call contract to Immudex USA, LLC for dextramers needed for human TARP studies. As part of its mission to support cancer research, the National Cancer Institute frequently contracts for specialized reagents and consumables from private sector suppliers. Immudex USA will deliver dextramers to support the agency's human TARP research program under this contract...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $47,575.30 firm fixed price purchase order to Immudex USA, LLC for custom T-cell receptor reagents. Per the original solicitation, Immudex will provide design of relevant TCR constructs, protein expression, quality control, and final production of these reagents. The reagents will support identification and enumeration of antigen presenting...

This federal contract award was made by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Immudex USA, LLC, a foreign-owned for-profit organization. The contract, valued at $4,770.75, is for the purchase of 500 tests of MHC Dextramer H-2 DB ABU-ABU-L-ABU-LTVFL PE. The contract is a firm fixed-price purchase order that was awarded on September 1, 2016, with a completion date of September 9, 2016. The contract has a...

<p>The National Cancer Institute issued a delivery order to Illumina, Inc. on August 15, 2016, with a ceiling value of $24,163.80 for reagents.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of September 14, 2016.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $60,305.60 firm fixed price delivery order to Illumina, Inc. for reagents and consumables. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is one month, from July 31, 2023 through August 30, 2023. No set aside designation or subcontractors were identified. This delivery order is likely in support of the...

<p>The National Cancer Institute awarded a purchase order to Irepertoire Inc. for $16,300 on September 21, 2020, with completion by October 30, 2020. The order is firm fixed price with no set-aside. Performance takes place in Huntsville, Alabama. The contractor will extract RNA, prepare cDNA, and sequence T-cell receptors from different mouse strains using multiplex PCR technology to quantitatively amplify cDNA of each T-cell receptor in provided tissue samples.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $93,969.03 firm fixed price delivery order contract to Illumina, Inc. for reagents and consumables. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is from December 20, 2023 through January 19, 2024. This delivery order was awarded under an existing government-wide acquisition contract vehicle or blanket...

<p>The National Cancer Institute issued a $17,792.10 delivery order to Illumina, Inc. on January 13, 2020, for reagents and consumables.</p> <p>Place of performance is Bethesda, MD 20892. Ultimate completion date is February 12, 2020. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute issued a $45,230.90 delivery order to Illumina, Inc. on August 5, 2020, for reagents and consumables, with an ultimate completion date of September 4, 2020.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute issued a $25,459.20 delivery order to Illumina, Inc. on August 27, 2020, for reagents and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order carries a firm fixed price and an ultimate completion date of September 26, 2020. No set-aside was used.</p>